{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:50:02Z","timestamp":1786996202963,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Pharm D thesis in Clinical Pharmacy of the Hebrew University"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.reprotox.2020.11.005","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:33:29Z","timestamp":1605526409000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study"],"prefix":"10.1016","volume":"99","author":[{"given":"Razan","family":"Sakran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Shechtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Arnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Diav-Citrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2020.11.005_bib0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pds.4185","article-title":"Antiemetic use among pregnant women in the United States: the escalating use of ondansetron","volume":"26","author":"Taylor","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200645040-00006","article-title":"Placental transfer of ondansetron during early human pregnancy","volume":"45","author":"Siu","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0015","first-page":"155","article-title":"Reproduction study (seg. II) of ondansetron hydrochloride in rats by intravenous route","volume":"20s","author":"Shimizu","year":"1992","journal-title":"Yakuri To Chiryo"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0020","first-page":"1187","article-title":"Reproduction study (seg. II) of ondansetron hydrochloride in rabbits by oral route","volume":"20s","author":"Ezaki","year":"1992","journal-title":"Yakuri To Chiryo"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1471-0528.2004.00236.x","article-title":"The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study","volume":"111","author":"Einarson","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0035","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.reprotox.2016.04.027","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States","volume":"62","author":"Fejzo","year":"2016","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0050","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformations and oral clefts in offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0055","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.reprotox.2018.10.010","article-title":"First trimester ondansetron exposure and risk of structural birth defects","volume":"83","author":"Zambelli-Weiner","year":"2019","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/ije\/dyz255","article-title":"Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defects","volume":"49","author":"Lemon","year":"2020","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"37","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"key":"10.1016\/j.reprotox.2020.11.005_bib0070","series-title":"Birth Defects and Drugs in Pregnancy","author":"Heinonen","year":"1977"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0075","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/1471-0528.12682","article-title":"Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study","volume":"121","author":"Ban","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.reprotox.2020.11.005_bib0080","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1093\/humrep\/deq260","article-title":"Severity and duration of nausea and vomiting symptoms in pregnancy and spontaneous abortion","volume":"25","author":"Chan","year":"2010","journal-title":"Hum. Reprod."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820302550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623820302550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:52:35Z","timestamp":1760190755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623820302550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":16,"alternative-id":["S0890623820302550"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.11.005","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcome following in-utero exposure to ondansetron: A prospective comparative observational study","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2020.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}